A Study of Brodalumab (SILIQ®) in Psoriasis Participants With Inadequate Response to Their Current Biologic Agent Regimen
Clinical trial NCT04149587 · COMPLETED
Trial details
- NCT number
- NCT04149587
- Sponsor
- Bausch Health Americas, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-09-30
- Primary completion
- 2022-03-30
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.